Skip to content

Clinical efficacy evaluation of acupotomy intervention and logistic regression analysis of influencing factors in frozen shoulder:a randomized controlled trial

Clinical efficacy evaluation of acupotomy intervention and logistic regression analysis of influencing factors in frozen shoulder:a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049220
Enrollment
Unknown
Registered
2021-07-25
Start date
2021-08-15
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder

Interventions

Sponsors

The First Affiliated Hospital of Yunnan University of Chinese Medicine/Yunnan Province Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. At the same time meet the diagnostic criteria and adhesion staging criteria for shoulder periarthritis; if combined with diabetes, the blood sugar should be controlled within the normal range; 2. Aged 40-65 years, no gender limit; 3. Unilateral disease; 4. No other treatment was received within 2 weeks; 5. Tolerable to blade needle minimally invasive surgery; 6. The patient who signed the informed consent form himself or his immediate family.

Exclusion criteria

Exclusion criteria: 1. Patients with shoulder pain in acute shoulder injury, incomplete fracture healing, shoulder bone tuberculosis, tumor, shoulder septic arthritis or attack of rheumatic immune system disease. 2. Combined with serious primary diseases such as cardiovascular and cerebrovascular or hematopoietic system. 3. Have a history of shoulder surgery. 4. Pregnant patients, lactating patients and patients who have childbearing requirements in the past six months. 5. Those who cannot understand or record relevant scoring indicators. 6. Patients with mental disorders such as intellectual disability, moderate or higher anxiety, depression, etc. 7. Those who are engaged in other pain-related disease drugs or physical therapy, or who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Surface electromyography (sEMG);Constant-Murley shoulder function score;

Secondary

MeasureTime frame
Perceptual pain quantitative analysis;

Countries

China

Contacts

Public ContactZhang Jingyu

The First Affiliated Hospital of Yunnan University of Chinese Medicine/Yunnan Province Hospital of Traditional Chinese Medicine

1299511124@qq.com+86 18788558393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026